A new device for the treatment of spinal cord injury could restore up to 80 per cent of a patient's normal functioning, it has been claimed.
Frank Reynolds, the head of InVivo Therapeutics, which is behind the technology, told the Boston Globe that trials on primates have proved successful.
He said: "100 percent of our monkeys have gotten up and walked in just about three weeks."
The device made from a biodegradable polymer that is implanted in the spinal cord of patients immediately after an injury and may include stem cells added to it, which trials have shown to markedly improve results.
It works by helping to stabilise the spine and allow neuroplasticity - the ability of the nervous system to work around damage.
His comments come as the company appoints Sean Moran as chief financial officer.
"In just a short time with InVivo, Sean has already shaped our financial strategies and we look forward to his continued contributions," said Mr Reynolds.
News from Serious Law, specialist spinal injury solicitors
Posted by Paul Breen